189 related articles for article (PubMed ID: 1560851)
21. Multiple myeloma: a tailored therapy for elderly patients.
Pileri A; Palumbo A; Boccadoro M
Hematol Oncol; 1993; 11 Suppl 1():67-72. PubMed ID: 8486344
[No Abstract] [Full Text] [Related]
22. [Therapy of multiple myeloma: present and future].
Tura S
G Clin Med; 1986 Dec; 67(5-6):261-4, 266-7. PubMed ID: 3301488
[No Abstract] [Full Text] [Related]
23. [Allogeneic bone marrow transplantation in multiple myeloma].
Bandini G; Rosti G; Cavo M; Albertazzi L; Rizzi S; Motta MR; Gobbi M; Tassi C; Tazzari PL; Miggiano C
Haematologica; 1989 Oct; 74(5 Suppl):463-72. PubMed ID: 2512229
[No Abstract] [Full Text] [Related]
24. [Status and trends in hematology].
Stobbe H
Z Arztl Fortbild (Jena); 1986; 80(18):741-4. PubMed ID: 3544527
[No Abstract] [Full Text] [Related]
25. VAMP followed by high dose melphalan and autologous bone marrow transplantation for multiple myeloma.
McElwain TJ; Gore ME; Meldrum M; Viner C; Judson IR; Malpas JS
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():109-12. PubMed ID: 2697419
[TBL] [Abstract][Full Text] [Related]
26. [Multiple myeloma -- therapy].
Jung W; Zettl F; Schroers R
Dtsch Med Wochenschr; 2005 Feb; 130(6):283-6; quiz 287-90. PubMed ID: 15692903
[No Abstract] [Full Text] [Related]
27. Transplantation in multiple myeloma.
Topolsky D; Biggs D
Semin Oncol; 1995 Jun; 22(3):230-7. PubMed ID: 7777867
[No Abstract] [Full Text] [Related]
28. The role of autologous stem cell transplantation in the management of multiple myeloma.
Fermand JP; Brechignac S
Pathol Biol (Paris); 1999 Feb; 47(2):199-202. PubMed ID: 10192889
[TBL] [Abstract][Full Text] [Related]
29. High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma.
Cavo M; Bandini G; Benni M; Gozzetti A; Ronconi S; Rosti G; Zamagni E; Lemoli RM; Bonini A; Belardinelli A; Motta MR; Rizzi S; Tura S
Bone Marrow Transplant; 1998 Jul; 22(1):27-32. PubMed ID: 9678792
[TBL] [Abstract][Full Text] [Related]
30. Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma.
Gertz MA; Lacy MQ; Inwards DJ; Chen MG; Pineda AA; Gastineau DA; Greipp PR; Lust JA; Tefferi A; Witzig TE; Kyle RA; Litzow MR
Bone Marrow Transplant; 1999 Feb; 23(3):221-6. PubMed ID: 10084252
[TBL] [Abstract][Full Text] [Related]
31. Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.
Rajkumar S; Fonseca R; Lacy M; Witzig T; Lust J; Greipp P; Therneau T; Kyle R; Litzow M; Gertz M
Bone Marrow Transplant; 1999 Sep; 24(5):497-503. PubMed ID: 10482933
[TBL] [Abstract][Full Text] [Related]
32. [Multiple myeloma].
Almazov VA; Afanasév BV; Podoltseva ZI
Klin Med (Mosk); 1993; 71(2):5-10. PubMed ID: 8046926
[No Abstract] [Full Text] [Related]
33. [High-dose melphalan in patients with multiple myeloma].
Moreau P; Le Bonniec M; Harousseau JL
Bull Cancer; 1999 Mar; 86(3):283-8. PubMed ID: 10210762
[TBL] [Abstract][Full Text] [Related]
34. High-dose chemotherapy in multiple myeloma.
Atkins CD
N Engl J Med; 1996 Dec; 335(24):1844; author reply 1845. PubMed ID: 8965895
[No Abstract] [Full Text] [Related]
35. [High-dose chemotherapy with autologous peripheral blood stem cell transplantation for the treatment of multiple myeloma refractory to conventional chemotherapy].
Shimokawa T; Kajiguchi T; Saito M; Kojima Y; Takeyama H
Gan To Kagaku Ryoho; 2003 Feb; 30(2):251-4. PubMed ID: 12610874
[TBL] [Abstract][Full Text] [Related]
36. Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation.
Inamoto Y; Kurahashi S; Imahashi N; Fukushima N; Adachi T; Kinoshita T; Tsushita K; Miyamura K; Naoe T; Sugiura I
Am J Hematol; 2009 May; 84(5):283-6. PubMed ID: 19338045
[TBL] [Abstract][Full Text] [Related]
37. Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma.
Harousseau JL; Attal M; Divine M; Milpied N; Marit G; Leblond V; Stoppa AM; Bourhis JH; Caillot D; Boasson M
Bone Marrow Transplant; 1995 Jun; 15(6):963-9. PubMed ID: 7581098
[TBL] [Abstract][Full Text] [Related]
38. Dose-intensified therapy combined with autologous blood stem cell support in patients with multiple myeloma.
Serke S; Kirsch A; Huhn D
Semin Oncol; 1994 Dec; 21(6 Suppl 16):29-32. PubMed ID: 7528448
[No Abstract] [Full Text] [Related]
39. [Progress in the treatment of multiple myeloma].
Wada M; Mizoguchi H
Gan To Kagaku Ryoho; 1997 Jul; 24(9):1079-88. PubMed ID: 9239160
[TBL] [Abstract][Full Text] [Related]
40. [Multiple myeloma: intensive chemotherapy and autotransplantation].
Jubert-Leleu MC
Soins; 1994 Oct; (589):34-6, 38. PubMed ID: 7676295
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]